company background image
MBOT logo

Microbot Medical NasdaqCM:MBOT Stock Report

Last Price

US$1.17

Market Cap

US$15.9m

7D

7.3%

1Y

-49.6%

Updated

25 Mar, 2024

Data

Company Financials +

Microbot Medical Inc.

NasdaqCM:MBOT Stock Report

Market Cap: US$15.9m

MBOT Stock Overview

Microbot Medical Inc. operates as a pre-clinical medical device company in the United Kingdom.

MBOT fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health4/6
Dividends0/6

Microbot Medical Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Microbot Medical
Historical stock prices
Current Share PriceUS$1.17
52 Week HighUS$4.37
52 Week LowUS$1.00
Beta1.65
1 Month Change-7.11%
3 Month Change-12.03%
1 Year Change-49.57%
3 Year Change-85.17%
5 Year Change-85.15%
Change since IPO-99.23%

Recent News & Updates

Is Microbot Medical (NASDAQ:MBOT) In A Good Position To Invest In Growth?

Dec 30
Is Microbot Medical (NASDAQ:MBOT) In A Good Position To Invest In Growth?

Recent updates

Is Microbot Medical (NASDAQ:MBOT) In A Good Position To Invest In Growth?

Dec 30
Is Microbot Medical (NASDAQ:MBOT) In A Good Position To Invest In Growth?

Is Microbot Medical (NASDAQ:MBOT) In A Good Position To Invest In Growth?

Sep 01
Is Microbot Medical (NASDAQ:MBOT) In A Good Position To Invest In Growth?

Here's Why We're A Bit Worried About Microbot Medical's (NASDAQ:MBOT) Cash Burn Situation

Dec 28
Here's Why We're A Bit Worried About Microbot Medical's (NASDAQ:MBOT) Cash Burn Situation

Microbot Medical acquires Nitiloop, terms undisclosed

Oct 07

Here's Why We're Watching Microbot Medical's (NASDAQ:MBOT) Cash Burn Situation

Sep 13
Here's Why We're Watching Microbot Medical's (NASDAQ:MBOT) Cash Burn Situation

Microbot Medical confirms GLP trial on track to begin later this month

Sep 02

Will Microbot Medical (NASDAQ:MBOT) Spend Its Cash Wisely?

Apr 23
Will Microbot Medical (NASDAQ:MBOT) Spend Its Cash Wisely?

Microbot Medical's Stryker Collaboration Makes This An Intriguing High Flier

Jan 06

Companies Like Microbot Medical (NASDAQ:MBOT) Are In A Position To Invest In Growth

Dec 24
Companies Like Microbot Medical (NASDAQ:MBOT) Are In A Position To Invest In Growth

We Think Microbot Medical (NASDAQ:MBOT) Can Afford To Drive Business Growth

Aug 27
We Think Microbot Medical (NASDAQ:MBOT) Can Afford To Drive Business Growth

Companies Like Microbot Medical (NASDAQ:MBOT) Are In A Position To Invest In Growth

May 12
Companies Like Microbot Medical (NASDAQ:MBOT) Are In A Position To Invest In Growth

We Think Microbot Medical (NASDAQ:MBOT) Can Afford To Drive Business Growth

Jan 27
We Think Microbot Medical (NASDAQ:MBOT) Can Afford To Drive Business Growth

Microbot Medical's study of surgical robotic system meets endpoints

Jan 14

Shareholder Returns

MBOTUS Medical EquipmentUS Market
7D7.3%-0.2%1.3%
1Y-49.6%10.6%29.8%

Return vs Industry: MBOT underperformed the US Medical Equipment industry which returned 11.2% over the past year.

Return vs Market: MBOT underperformed the US Market which returned 30.4% over the past year.

Price Volatility

Is MBOT's price volatile compared to industry and market?
MBOT volatility
MBOT Average Weekly Movement19.2%
Medical Equipment Industry Average Movement7.8%
Market Average Movement6.0%
10% most volatile stocks in US Market16.8%
10% least volatile stocks in US Market3.0%

Stable Share Price: MBOT's share price has been volatile over the past 3 months.

Volatility Over Time: MBOT's weekly volatility has decreased from 27% to 19% over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
201018Harel Gadothttps://www.microbotmedical.com

Microbot Medical Inc. operates as a pre-clinical medical device company in the United Kingdom. It primarily engages in the research, design, and development of next generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company also offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces.

Microbot Medical Inc. Fundamentals Summary

How do Microbot Medical's earnings and revenue compare to its market cap?
MBOT fundamental statistics
Market capUS$15.94m
Earnings (TTM)-US$10.58m
Revenue (TTM)n/a

0.0x

P/S Ratio

-1.5x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
MBOT income statement (TTM)
RevenueUS$0
Cost of RevenueUS$0
Gross ProfitUS$0
Other ExpensesUS$10.58m
Earnings-US$10.58m

Last Reported Earnings

Sep 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.79
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0%

How did MBOT perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.